5'-Methyl-5'-[5-(m,m,p-trimethoxybenzoyloxymethyl)-uracil-1-ylmethyl]-2'-oxo-3'-methylenetetrahydrofuran

ID: ALA3276959

PubChem CID: 12381711

Max Phase: Preclinical

Molecular Formula: C22H24N2O9

Molecular Weight: 460.44

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C1CC(C)(Cn2cc(COC(=O)c3cc(OC)c(OC)c(OC)c3)c(=O)[nH]c2=O)OC1=O

Standard InChI:  InChI=1S/C22H24N2O9/c1-12-8-22(2,33-19(12)26)11-24-9-14(18(25)23-21(24)28)10-32-20(27)13-6-15(29-3)17(31-5)16(7-13)30-4/h6-7,9H,1,8,10-11H2,2-5H3,(H,23,25,28)

Standard InChI Key:  MZVDXORGVAWLMU-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 33 35  0  0  0  0  0  0  0  0999 V2000
   31.2794   -7.3417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.2794   -8.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9914   -8.5750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.7034   -8.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7034   -7.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9914   -6.9251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9914   -6.1001    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.5655   -8.5803    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.4191   -6.9313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9914   -9.4000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2769   -9.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5231   -9.4820    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.9711  -10.0951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3837  -10.8096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1905  -10.6380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1506  -10.0088    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.0481  -11.5633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9877  -10.2250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1324   -7.3459    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.8481   -6.9355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5613   -7.3501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8505   -6.1105    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.5575   -8.1761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2699   -8.5907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9866   -8.1802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9864   -7.3509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2734   -6.9401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7005   -8.5938    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.6991   -9.4188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7006   -6.9380    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.4153   -7.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2671   -9.4157    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.5512   -9.8257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  2  8  2  0
  5  9  1  0
  3 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 11  1  0
 13 16  2  0
 14 17  2  0
 11 18  1  0
  9 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  2  0
 21 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 21  1  0
 25 28  1  0
 28 29  1  0
 26 30  1  0
 30 31  1  0
 24 32  1  0
 32 33  1  0
M  END

Associated Targets(non-human)

W256 (236 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
P388 (20296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
B16 (5829 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 460.44Molecular Weight (Monoisotopic): 460.1482AlogP: 1.18#Rotatable Bonds: 8
Polar Surface Area: 135.15Molecular Species: NEUTRALHBA: 10HBD: 1
#RO5 Violations: HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.64CX Basic pKa: CX LogP: 1.51CX LogD: 1.51
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.45Np Likeness Score: 0.15

References

1. Lee KH, Wu YS, Hall IH..  (1977)  Antitumor agents. 25. Synthesis and antitumor activity of uracil and thymine alpha-methylene-gamma-lactones and related derivatives.,  20  (7): [PMID:874966] [10.1021/jm00217a009]

Source